Clinical Trial of Rituximab in Children and Adolescents With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Phase 1
Completed
- Conditions
- Idiopathic Thrombocytopenic Purpura (ITP)Immune Thrombocytopenic Purpura (ITP)
- Interventions
- First Posted Date
- 2012-10-25
- Last Posted Date
- 2012-11-09
- Lead Sponsor
- Neufeld, Ellis J, MD, PhD
- Target Recruit Count
- 36
- Registration Number
- NCT01713738
- Locations
- ๐บ๐ธ
Stanford University School of Medicine, Palo Alto, California, United States
๐บ๐ธUniversity of California, San Francisco, San Francisco, California, United States
๐บ๐ธEmory University School of Medicine, Atlanta, Georgia, United States
Vaccine Response After Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura
Not Applicable
Completed
- Conditions
- Idiopathic Thrombocytopenic PurpuraImmune Thrombocytopenic Purpura
- First Posted Date
- 2012-10-25
- Last Posted Date
- 2012-10-25
- Lead Sponsor
- Neufeld, Ellis J, MD, PhD
- Target Recruit Count
- 10
- Registration Number
- NCT01713855
- Locations
- ๐บ๐ธ
Emory University School of Medicine, Atlanta, Georgia, United States
๐บ๐ธChildren's Hospital, Boston, Massachusetts, United States
๐บ๐ธUniversity of California, Los Angeles, Los Angeles, California, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath